204 related articles for article (PubMed ID: 26779633)
1. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
[TBL] [Abstract][Full Text] [Related]
2. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19.
Fang Y; Fu D; Tang W; Cai Y; Ma D; Wang H; Xue R; Liu T; Huang X; Dong L; Wu H; Shen X
Biochim Biophys Acta; 2013 Mar; 1833(3):559-72. PubMed ID: 23220010
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.
Liao M; Tong P; Zhao J; Zhang Y; Li Z; Wang J; Feng X; Hu M; Pan Y
Pathol Oncol Res; 2012 Apr; 18(2):397-403. PubMed ID: 21909684
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
Cui J; Yu Y; Lu GF; Liu C; Liu X; Xu YX; Zheng PY
Tumour Biol; 2013 Jun; 34(3):1913-8. PubMed ID: 23516026
[TBL] [Abstract][Full Text] [Related]
10. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
Ishibashi M; Kogo R; Shibata K; Ueo H; Uchi R; Matsumura T; Takano Y; Sawada G; Takahashi Y; Mima K; Kurashige J; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Suzuki A; Wakabayashi G; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S537-44. PubMed ID: 23532381
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.
Kim JM; Kwon CH; Joh JW; Ko JS; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
World J Surg Oncol; 2013 Apr; 11():92. PubMed ID: 23618082
[TBL] [Abstract][Full Text] [Related]
14. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
Lin ZZ; Jeng YM; Hu FC; Pan HW; Tsao HW; Lai PL; Lee PH; Cheng AL; Hsu HC
BMC Cancer; 2010 Aug; 10():461. PubMed ID: 20799978
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
Zhang G; Liu T; Wang Z
J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
[TBL] [Abstract][Full Text] [Related]
16. High expression of patched homolog-1 messenger RNA and glioma-associated oncogene-1 messenger RNA of sonic hedgehog signaling pathway indicates a risk of postresection recurrence of hepatocellular carcinoma.
Jeng KS; Sheen IS; Jeng WJ; Lin CC; Lin CK; Su JC; Yu MC; Fang HY
Ann Surg Oncol; 2013 Feb; 20(2):464-73. PubMed ID: 22911366
[TBL] [Abstract][Full Text] [Related]
17. Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma.
Zhao G; Huang ZM; Kong YL; Wen DQ; Li Y; Ren L; Zhang HY
World J Surg Oncol; 2013 Mar; 11():74. PubMed ID: 23518204
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
[TBL] [Abstract][Full Text] [Related]
19. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.
Liu YB; Gao SL; Chen XP; Peng SY; Fang HQ; Wu YL; Peng CH; Tang Z; Xu B; Wang JW; Deng GL; Li HJ; Feng XD; Qian HR
World J Gastroenterol; 2005 Mar; 11(9):1378-81. PubMed ID: 15761980
[TBL] [Abstract][Full Text] [Related]
20. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.
Fan MQ; Huang CB; Gu Y; Xiao Y; Sheng JX; Zhong L
J Exp Clin Cancer Res; 2013 Apr; 32(1):21. PubMed ID: 23594563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
